Search Results 501-510 of 3033 for 谷歌日本搜索引入口咨询邮箱：lgooxc@hotmail.com
These subjects will be followed for safety monitoring on a schedule of decreasing frequency through 15 years post-ACTR treatment, in accordance with US FDA ...
The purpose of this first-in-human study is to evaluate the safety, pharmacokinetics and preliminary effectiveness of STRO-001 given intravenously every 2 weeks ...
Mayo Clinic expects suppliers and their representatives to uphold the same high standards of ethical behavior, integrity and professionalism that are ...
The purpose of this study will evaluate the safety and effectiveness of VE303 for participants with recurrent Clostridium difficile infection (rCDI).
About this study. The purpose of this study with the Health Authorities from the United States (US), Canada and Europe, is to collect long-term safety ...
Serum (up to 10 ml) will be obtained within two weeks of renal biopsy either as waste from the Mayo Clinic Rochester Central Clinical Laboratory or a referring ...
About this study. The overall goal of this proposal is to determine the effects of acute hyperglycemia and its modulation by Glucagon-like Peptide-1 (GLP-1) ...
The purpose of this study is to test the validity of Multiscent in the USA population by studying the correlation and agreement between Multiscent and UPSIT ...
About this study. The purpose of this study is to to survey patients (or their parents) who have been photographed using the PhotoExam application to better ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.